Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1982 5
1983 5
1984 11
1985 11
1986 16
1987 14
1988 19
1989 40
1990 53
1991 57
1992 97
1993 155
1994 251
1995 334
1996 358
1997 347
1998 385
1999 354
2000 350
2001 363
2002 347
2003 339
2004 351
2005 332
2006 355
2007 367
2008 450
2009 450
2010 507
2011 579
2012 626
2013 655
2014 661
2015 620
2016 617
2017 573
2018 547
2019 533
2020 501
2021 435
2022 309
2023 283
2024 353
2025 443
2026 202

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,357 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of CD44 antigen in type 2 diabetic patients with periodontitis: An immunohistochemical study.
Arumuganainar D, Krishna Naik V, Ramadoss R, Balasundaram A, Victor DJ. Arumuganainar D, et al. Dent Med Probl. 2024 Mar-Apr;61(2):225-231. doi: 10.17219/dmp/156225. Dent Med Probl. 2024. PMID: 38567731 Free article.
BACKGROUND: Type 2 diabetes mellitus (DM) is a known systemic risk factor for periodontitis. An increased expression of CD44 has been suggested in type 2 diabetics and periodontitis patients. OBJECTIVES: The present study aimed to assess the expression of CD44 an …
BACKGROUND: Type 2 diabetes mellitus (DM) is a known systemic risk factor for periodontitis. An increased expression of CD44 has been …
CD44-Associated Tn Antigen as a New Biomarker of Tumor Cells with Aberrant Glycosylation.
Shuvalova ML, Kopylov AT, Mazurov DV, Pichugin AV, Bovin NV, Filatov AV. Shuvalova ML, et al. Biochemistry (Mosc). 2020 Sep;85(9):1064-1081. doi: 10.1134/S0006297920090060. Biochemistry (Mosc). 2020. PMID: 33050853 Free article.
Tn antigen is a tumor-associated antigen that appears on cancer cells as a result of aberrant O-glycosylation. The most studied form of Tn antigen is found in mucins, in particular, in mucin 1 (MUC1). Antibodies against this form of Tn antigen are used …
Tn antigen is a tumor-associated antigen that appears on cancer cells as a result of aberrant O-glycosylation. The most studie …
CD44 cross-linking promotes Plasmodium falciparum invasion.
Kongsomboonvech AK, Scally SW, Le Guen Y, Valissery P, Salinas ND, Cowman AF, Tolia NH, Egan ES. Kongsomboonvech AK, et al. Nat Commun. 2025 Dec 7;17(1):319. doi: 10.1038/s41467-025-67030-x. Nat Commun. 2025. PMID: 41354647 Free PMC article.
Here, we identify an anti-CD44 monoclonal antibody, BRIC 222, that significantly promotes P. falciparum invasion through CD44 cross-linking. ...The parasite ligand Erythrocyte Binding Antigen-175 (EBA-175), which interacts with CD44, enhanced P. falcip …
Here, we identify an anti-CD44 monoclonal antibody, BRIC 222, that significantly promotes P. falciparum invasion through CD44 …
The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Ralpha-armored CAR-T cells against glioblastoma.
Zhai Y, Li G, Pan C, Yu M, Hu H, Wang D, Shi Z, Jiang T, Zhang W. Zhai Y, et al. Cancer Lett. 2025 Apr 1;614:217541. doi: 10.1016/j.canlet.2025.217541. Epub 2025 Feb 12. Cancer Lett. 2025. PMID: 39952598 Free article.
In this context, we developed a tandem chimeric antigen receptor (CAR)-T cell targeting CD44 and CD133 (PROM1), containing a truncated IL-7 receptor alpha intracellular domain (delta7R) between the CD28 costimulatory receptor and the CD3zeta signaling chain (Tanzeta …
In this context, we developed a tandem chimeric antigen receptor (CAR)-T cell targeting CD44 and CD133 (PROM1), containing a t …
CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer.
Tang J, Li X, Tang N, Lin X, Du Y, Zhang S, Li Q, Zhang Y, Zhang Y, Hang H, Qiu T, Qiu Y, Cheng H, Dai Z, Hong H, Wei W, He J, Yan C. Tang J, et al. Cancer Lett. 2025 Jul 10;622:217713. doi: 10.1016/j.canlet.2025.217713. Epub 2025 Apr 9. Cancer Lett. 2025. PMID: 40216152
Furthermore, we developed a radionuclide-labeled CD44 antibody (89)Zr-1M2E3, which specifically recognized CA19-9 negative PDAC tumors in preclinical models using PET-CT imaging. These findings highlight CD44 as a promising biomarker and therapeutic target for diagn …
Furthermore, we developed a radionuclide-labeled CD44 antibody (89)Zr-1M2E3, which specifically recognized CA19-9 negative PDAC tumor …
Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas.
Savli TB, Pasaoglu HE, Savli TC, Muhammedoglu A, Tokocin M, Öztürk Ç. Savli TB, et al. Rev Assoc Med Bras (1992). 2023 Jul 17;69(7):e20230371. doi: 10.1590/1806-9282.20230371. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37466609 Free PMC article.
OBJECTIVE: The expression of cytotoxic T lymphocyte-associated antigen 4, E-cadherin, and CD44 in the area of tumor budding was investigated in breast carcinomas in our study. ...To understand the microenvironment of tumor budding, we examined the expression status …
OBJECTIVE: The expression of cytotoxic T lymphocyte-associated antigen 4, E-cadherin, and CD44 in the area of tumor budding wa …
The role of CD44 in glioblastoma multiforme.
Mooney KL, Choy W, Sidhu S, Pelargos P, Bui TT, Voth B, Barnette N, Yang I. Mooney KL, et al. J Clin Neurosci. 2016 Dec;34:1-5. doi: 10.1016/j.jocn.2016.05.012. Epub 2016 Aug 28. J Clin Neurosci. 2016. PMID: 27578526 Review.
The role of CD44 has been examined in many cancer types. This paper provides, to our knowledge, the first focused review of the role of CD44 in glioblastoma multiforme (GBM), the most common and fatal of primary brain cancers. ...Effects of CD44 inhibition in …
The role of CD44 has been examined in many cancer types. This paper provides, to our knowledge, the first focused review of the role …
Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.
Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, Liu J, Zhang S, Iwamori M. Gao L, et al. J Exp Clin Cancer Res. 2011 Feb 7;30(1):15. doi: 10.1186/1756-9966-30-15. J Exp Clin Cancer Res. 2011. PMID: 21294926 Free PMC article.
BACKGROUND: This study aimed to investigate the molecular structural relationship between cell adhesive molecule CD44 and Lewis y antigen, and determine the effects of Lewis y antigen on CD44-mediated adhesion and spreading of ovarian cancer cell line …
BACKGROUND: This study aimed to investigate the molecular structural relationship between cell adhesive molecule CD44 and Lewis y …
Critical Involvement of CD44 in T Helper Type 2 Cell-Mediated Eosinophilic Airway Inflammation in a Mouse Model of Acute Asthma.
Katoh S. Katoh S. Front Immunol. 2022 Jan 7;12:811600. doi: 10.3389/fimmu.2021.811600. eCollection 2021. Front Immunol. 2022. PMID: 35069598 Free PMC article. Review.
Administration of anti-CD44 monoclonal antibodies preferentially suppressed the airway accumulation of antigen-specific Th2 cells induced by antigen challenge, without affecting Th1 and Th17 cells. Increased HA-binding ability of CD44 and expression of …
Administration of anti-CD44 monoclonal antibodies preferentially suppressed the airway accumulation of antigen-specific Th2 ce …
Driving cancer evolution.
Fitzgerald DM, Rosenberg SM. Fitzgerald DM, et al. Elife. 2017 Mar 10;6:e25431. doi: 10.7554/eLife.25431. Elife. 2017. PMID: 28282287 Free PMC article.
13,357 results
You have reached the last available page of results. Please see the User Guide for more information.